1. Combe B. The french early arthritis register. Clinical and Experimental Rheumatology 2003,(suppl.31), S123-S129
    voir l'article : ESPOIR 1

  2. Combe B, BenessianoJ, BerenbaumF, Cantagrel A, Daurès JP, Dougados M, Fardellone P, Fautrel B, Flipo RM, Goupille P, Guillemin F, Le Loet X., Logeart I, Mariette X, Meyer O, Ravaud P, Rincheval N, Saraux A. , Schaeverbeke T. , Sibilia J. The ESPOIR cohort : a ten-year follow-up of early arthritis in France. Methodology and baseline characteristics of the 813 included patients.   Joint Bone Spine 2007 Oct;74(5):440-5. Epub 2007 Jul 26.
    voir l'article : ESPOIR 2

  3. Devauchelle V, Josseaume T, Samjee I, Dougados M, Combe B, Saraux A. Ability of oblique foot radiographs to detect erosions in early arthritis: Results in the ESPOIR cohort. Arthritis Rheum. 2008;59:1729-34.
    voir l'article : ESPOIR 3

  4. Lukas C, Guillemin F, Landewé R, van der Heijde D, Logeart I, Fautrel B ,Daures JP, Combe B. Factors determining a DMARD initiation in early arthritis patients. The ESPOIR cohort study. Clin Exp Rheumatol 2009; 27: 84-91
    voir l'article : ESPOIR 4

  5. Benhamou M, Rincheval N, Roy C, Foltz V, Rozenberg S, Sibilia J, Schaeverbeke T, Bourgeois P, Ravaud P, Fautrel B. The Gap Between Practice and Guidelines in the Choice of First-line Disease Modifying Antirheumatic Drug in Early Rheumatoid Arthritis: Results from the ESPOIR Cohort. J Rheumatol 2009; 36:5; doi:10.3899/jrheum.080762
    voir l'article : ESPOIR 5

  6. Gottenberg JE, Miceli-Richard C, Ducot B, Goupille P, Combe B, Mariette X. Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort. Arthritis. Res Ther. 2009;11(4):R114.
    voir l'article : ESPOIR 6

  7. Guennoc X, Narbonne V, Jousse-Joulin S, Devauchelle-Pensec V, Dougados M, Daurres JP, Saraux A. Is Screening for Hepatitis B and C Useful in Patients with Recent-Onset Polyarthritis?       Results of the ESPOIR cohort study.  J Rheumatol  2009 Jul;36(7):1407-13.
    voir l'article : ESPOIR 7

  8. Funck-Brentano T, Etchepare F, Joulin SJ, Gandjbakch F, Pensec VD, Cyteval C, Miquel A, Benhamou M, Banal F, Le Loet X, Cantagrel A, Bourgeois P, Fautrel B. Benefits of ultrasonography in the management of early arthritis: a cross-sectional study of baseline data from the ESPOIR cohort. Rheumatology (Oxford). 2009 Dec;48(12):1515-9.
    voir l'article : ESPOIR 8

  9. Fautrel B, Benhamou M, Foltz V, Rincheval N, Rat AC, Combe B, Berenbaum F, Bourgeois P, Guillemin F. Early referral to the rheumatologist for early arthritis patients: evidence for suboptimal care. Results from the ESPOIR cohort. Rheumatology (Oxford). 2010 Jan;49(1):147-55.
    voir l'article : ESPOIR 9

  10. Salliot C, Bombardier C, Saraux A, Combe B, Dougados M. Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort. Ann Rheum Dis. 2010 Apr 13. [Epub ahead of print] PubMed PMID: 19740903.
    voir l'article : ESPOIR 10

  11. Cyteval C, Miquel A, Hoa D, Daures JP, Mariette X, Combe B. Rheumatoid Arthritis of the Hand: Monitoring with a Simplified MR Imaging Scoring Method--Preliminary Assessment. Radiology. 2010 ;256:863-9. Epub 2010 Jul 27.
    voir l'article : ESPOIR 11

  12. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010 Sep;69:1580-8 et Arthritis Rheum. 2010 ;62:2582-91.
    voir l'article : ESPOIR 12

  13. Gossec L, Combescure C, Rincheval N, Saraux A, Combe B, Dougados M.Relative Clinical Influence of Clinical, Laboratory, and Radiological Investigations in EarlyArthritis on the Diagnosis of Rheumatoid Arthritis. Data from the French Early Arthritis  Cohort ESPOIR. J Rheumatol. 2010 Oct 15.
    voir l'abstract : ESPOIR 13
    voir l'article : ESPOIR 13

  14. Soubrier M, Lukas C, Sibilia J, Fautrel B, Roux F, Patternotte S, Dougados D. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: Data from the GUEPARD trial and ESPOIR cohort. Ann Rheum Dis 2011
    voir l'article : ESPOIR 14

  15. Millot F, Clavel G et al. Musculoskeletal ultrasonography in healthy subjects andultrasound criteria for early arthritis (the ESPOIR cohort).  J Rheumatol 2011(in press)
    voir l'article : ESPOIR 15

  16. Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM,Fardelone P,Bourgeois P,Fautrel B Comparison of the EQ-5D and the Short Form 6D utility measures in French patients with early arthritis: Results from the ESPOIR cohort. J Rheumatol 2011 Aug;38(8):1576-84. Epub 2011 May 1.
    voir l'article : ESPOIR 16

  17. Lukas C, Combe B, Ravaud Ph, Sibilia J, Landewé R, van der Heijde D. Very early DMARD initiation in inflammatory arthritis is effective in inhibition of radiographic progression. Arthritis Rheumatism 2011 Jul;63(7):1804-11. doi: 10.1002/art.30371
    voir l'article : ESPOIR 17

  18. Mouterde G , Lukas C, Logeart I, Flipo RM, Rincheval N, Daurès JP, Combe B Predictors of radiographic progression in the ESPOIR cohort. The season of first symptoms may influence the short-term outcome in early arthritis. Annals of Rheumatic Diseases 2011 Jul;70(7):1251-6. Epub 2011 Apr 22
    voir l'article : ESPOIR 18

  19. Varache S, Narbonne V, Jousse-Joulin S, Guennoc X, Dougados M, Daurès JP, Devauchelle-Pensec V, Saraux A Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study. Arthritis Care Res (Hoboken). 2011 ;63:1565-70. doi: 10.1002/acr.20576
    voir l'article : ESPOIR 19

  20. Salliot C, Dawidowicz K, Lukas C, Guedj M, Paccard C, Benessiano J, Dougados M, Nicaise P, Meyer O, Dieudé P.PTPN22 R620W genotype-phenotype correlation analysis and gene-environment interaction study in early rheumatoid arthritis: results from the ESPOIR cohort. Rheumatology (Oxford). 2011; 50 :1802-8. Epub ahead of print 2011 Jul 13
    voir l'article : ESPOIR 20

  21. Fautrel B, Combe B, Rincheval N, Dougados M; for the ESPOIR Scientific Committee. Level of agreement of the 1987 ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: an analysis based on ESPOIR cohort data. Ann Rheum Dis. 2011 71:386-9. Epub 2011Oct 28.
    voir l'article : ESPOIR 21

  22. Boyer JF, Bongard V, Cantagrel A, Jamard B, Gottenberg JE, Mariette X, Davignon JL, Ferrières J, Ruidavets JB, Dallongeville J, Arveiler D, Cambon-Thomsen A, Constantin A. Link between traditional cardiovascular risk factors and inflammation in early arthritis patients.Arthritis Care Res (Hoboken). 2012 64:872-80. Epub 2012 Jan 24
    voir l'article : ESPOIR 22

  23. Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B. Responsiveness of the EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort. Annals Rheum Dis. 2012 71:1478-83. Epub 2012 Mar 14
    voir l'article : ESPOIR 23

  24. Rat AC, Pouchot J, Fautrel B, Boumier P, Goupille P, Guillemin F. Factors associated with fatigue in early arthritis: Results from the ESPOIR cohort. Arthritis Care Res (Hoboken). 2012 Feb 21. doi: 10.1002/acr.21647. [Epub ahead of print]
    voir l'article : ESPOIR 24

  25. Escalas C, Dalichampt M, Combe B, Fautrel B, Guillemin F, Durieux P, Dougados M, Ravaud P. Effect of adherence to European treatment guidelines on early arthritis outcome Ann Rheum Dis. 2012 May 6. [Epub ahead of print]
    voir l'article : ESPOIR 25

  26. Gottenberg JE, Dayer JM, Lukas C, Ducot B, Chiocchia G, Cantagrel A, Saraux A, Roux-Lombard P, Mariette X. Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort. Ann Rheum Dis. 2012 71:1243-8. Epub 2012 Apr 24
    voir l'article : ESPOIR 26

  27. Gaujoux-Viala C, Paternotte S, Combe B, Dougados M. Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its sub-optimal use: results from the ESPOIR early synovitis cohort. Rheumatology (Oxford). 2012 Jul 19. [Epub ahead of print]
    voir l'article : ESPOIR 27

  28. Nicaise-Roland P, Nogueira L, Demattei C, de Chaisemartin L, Rincheval N, Cornillet M, Grootenboer-Mignot S, Dieudé P, Dougados M, Cantagrel A, Meyer O, Serre G, Chollet-Martin S. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort. Ann Rheum Dis. 2012 May 12. [Epub ahead of print]
    voir l'article : ESPOIR 28

  29. Zhang B, Combe B, Rincheval N, Felson DT. Validation of ACR/EULAR Definition of Remission in Rheumatoid Arthritis from RA Practice: The ESPOIR cohort. Arthritis Research & Therapy 2012 29;14:R156. [Epub ahead of prin
    voir l'article : ESPOIR 29

  30. Gaujoux-Viala C, Fautrel B, Guillemin F, Flipo RM, Bourgeois P, Rat AC. Who are the patients with early arthritis with worse than death scores on the EQ-5D? Results from the ESPOIR cohort.Rheumatology (Oxford). 2013 May;52(5):832-8. doi: 10.1093/rheumatology/kes270. Epub 2012 Oct 22
    voir l'article : ESPOIR 30

  31. Fautrel B, Granger B, Combe B, Le Loet X on behalf of the ESPOIR Scientific Committee Risk model of rapid radiographic progression in early rheumatoid arthritis treated by methotrexate in the ESPOIR cohort Arthritis Research & Therapy 2012 19;14:R249. [Epub ahead of print]
    voir l'article : ESPOIR 31

  32. Sellam J,Kotti S, Fellahi S, Bastard JP, Meyer M, Lioté F, Meyer O, Simon T, Capeau J, Berenbaum F. Serum hepcidin level is not an independent surrogate biomarker of disease activity or of radiographic progression in rheumatoid arthritis : results from ESPOIR cohort Ann Rheum Dis 2012Nov 12. [Epub ahead of print (letter)
    voir l'article : ESPOIR 32

  33. Saraux A, Tobon GJ, Benhamou M, Devauchelle-Pensec V, Dougados M, Mariette X, Meyer O, Berenbaum F, Chiocchia G, Rat AC, Schaeverbecke Th, Rincheval N, Fautrel B, Combe B. Potential classification criteria for rheumatoid Arthritis after two years: Results from a French multicenter cohort. Arthritis Care Research 2013 Aug;65(8):1227-34. doi: 10.1002/acr.21982.
    voir l'article : ESPOIR 33

  34. Castrejon I, Pincus T, Soubrier M, Chang Lin Y, Rat AC, Combe B ,Dougados M . GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate . Rheumatology (Oxford). 2013 Oct;52(10):1890-7. doi: 10.1093/rheumatology/ket230. Epub 2013 Jul 17
    voir l'article : ESPOIR 34

  35. Funck-Brentano T,Grandjbakhch F,Etchepare F, Jousse-Joulin S, Miquel A,Cyteval C,Lukas C, Tobon G, Saraux A, Boumier P, Goupille P, Bourgeois P, Fautrel B. Sonographic erosions and power-Doppler signal predict radiographic damage in early arthritis : The ESPOIR ultrasonographiy longitudinal study. Arthritis Care & Research 2012 Dec 4. doi: 10.1002/acr.21912. [Epub ahead of print]
    voir l'article : ESPOIR 35

  36. Castrejon I, Pincus T, Guillemin F, Fautrel B, Combe B ,Dougados M. Possible remission criteria in rheumatoid arthritis without a formal joint count, based on careful joint examination and self-report RAPID3 score : Data from the ESPOIR usual care cohort. J Rheumatol. 2013 Apr;40(4):386-93. doi: 10.3899/jrheum.121059. Epub 2013 Feb 1.
    voir l'article : ESPOIR 36

  37. Le Boëdec M, Marhadour T, Devauchelle-Pensec V, Jousse-Joulin S, Binard A, Fautrel B, Flipo RM, Le Loët X, Ménard JF, Saraux A.Baseline laboratory test abnormalities are common in early arthritis but rarely contraindicate methotrexate: study of three cohorts (ESPOIR, VErA, and Brittany).Semin Arthritis Rheum. 2013 Apr;42(5):474-81. doi: 10.1016/j.semarthrit.2012.08.001. Epub 2013 Jan 24.
    voir l'article : ESPOIR 37

  38. Knevel R, Lukas C, van der Heijde D, Rincheval N2,Combe B, van der Helm-van Mil A. Defining erosive disease typical of RA in the light of the ACR/EULAR 2010 criteria for Rheumatoid Arthritis; results of the data-driven phase. Annals of the Rheumatic Diseases 2013 Apr;72:590-5
    voir l'article : ESPOIR 38

  39. van der Heijde D, H.M. van der Helm-van Mil A, Aletaha D, Bingham C, Burmester G, Dougados M, Emery P, Felson D, Knevel R, Kvien TK, Landewé R, Lukas C, McInnes I, Silman I, Smolen J, Stanislawska-Biernat E, Zink A, Combe B. EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria. Annals of Rheumatic the Diseases 2013 ;72:479-81
    voir l'article : ESPOIR 39

  40. Vesperini V, Lukas C, Fautrel B, Le Loet X,Rincheval N, Combe B Does cigarette smoking influence activity and severity in early rheumatoid arthritis? Results from the ESPOIR cohort. Arthritis Care Research 2013 Jul 8. doi: 10.1002/acr.22057. [Epub ahead of print]
    voir l'article : ESPOIR 40

  41. Combe B , Rincheval N, Benessiano J, Berenbaum F, Cantagrel A, Daurès JP, Dougados M, Fardellone P, Fautrel B, Flipo RM, Goupille P, Guillemin F, Le Loet X, Logeart I, Mariette X, Meyer O, Ravaud P, Saraux A, Schaeverbeke T, Sibilia J. Five-year favourable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort. Journal of Rheumatology 2013 Oct;40(10):1650-7. doi: 10.3899/jrheum.121515. Epub 2013 Aug 15.
    voir l'article : ESPOIR 41

  42. TobonG, Saraux A,Lukas C,Grandjbakhch F,Gottenberg JE, Mariette X, Combe B, Devauchelle-Pensec V. First-Year Radiographic Progression is the Best Predictor of Further Progression in Early Arthritis: Results of a Large National French Cohort. Arthritis Care Research 2013 Jul 16. doi: 10.1002/acr.22078. [Epub ahead of print]
    voir l'article : ESPOIR 42

  43. Gossec L, Paternotte S, Combe B, Meyer O, Dougados M. Repeated anti-citrullinated protein antibody and rheumatoid factor assessment is not necessary in early arthritis. Results from the ESPOIR cohort. J Rheumatol 2014 Jan;41(1):41-6. doi: 10.3899/jrheum.121313. Epub 2013 Nov 15.
    voir l'article : ESPOIR 43

  44. Ruyssen-Witrand A, Lukas C, Nigon D, Dawidowicz K, Morel J, Sibilia J, Jamard B, Cambon-Thomsen A, Cantagrel A, Dieudé P, Constantin A. Association of IL-2RA and IL-2RB genes with erosive status in early rheumatoid arthritis patients (ESPOIR and RMP cohorts). Joint Bone Spine. 2013 Nov 4. pii: S1297-319X(13)00242-X. doi: 10.1016/j.jbspin.2013.10.002. [Epub ahead of print]
    voir l'article : ESPOIR 44

  45. Combe B, Logeart I, Belkacemi M, Dadoun S, Schaeverbeke T, Daurès JP, Dougados M. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort. Ann Rheum Dis 2014 Jan 7. doi: 10.1136.
    voir l'article : ESPOIR 45

  46. Meyer M, Sellam J, Fellahi S, Kotti S, Bastard JP, Meyer O, Lioté F, Simon T, Capeau J, Berenbaum F. Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort. Arthritis Res Ther. 2013 Dec 9;15(6):R210. [Epub ahead of print]
    voir l'article : ESPOIR 46

  47. Dadoun S, Guillemin F, Lucier S, Looten V, Saraux A, Berenbaum F, Durand-Zaleski I, Chevreul K, Fautrel B. Work productivity loss in early arthritis during the first 3 years of disease. A study from the ESPOIR cohort. Arthritis Care Res (Hoboken). 2014 Sep;66(9):1310-8. doi: 10.1002/acr.22298.
    voir l'article : ESPOIR 47

  48. Gazal S1, Sacre K, Allanore Y, Teruel M, Goodall AH; (The CARDIOGENICS consortium), Tohma S, Alfredsson L, Okada Y, Xie G, Constantin A, Balsa A, Kawasaki A, Nicaise P, Amos C, Rodriguez-Rodriguez L, Chioccia G, Boileau C, Zhang J, Vittecoq O, Barnetche T, Gonzalez Gay MA, Furukawa H, Cantagrel A, Le Loët X, Sumida T, Hurtado-Nedelec M, Richez C, Chollet-Martin S, Schaeverbeke T, Combe B, Khoryati L, Coustet B, El-Benna J, Siminovitch K, Plenge R, Padyukov L, Martin J, Tsuchiya N, Dieudé P. . Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene Ann Rheum Dis. 2014 Jan 21. doi: 10.1136/annrheumdis-2013-204581. [Epub ahead of
    voir l'article : ESPOIR 48

  49. Cornillet M, Ruyssen-Witrand A, Constantin A, Meyer O, Cantagrel A, Serre G, Nogueira L. 1.60 Autoantibodies to human citrullinated fibrinogen (AhFibA) and their subfamilies directed to the fibrin peptides α36-50Cit38,42 and β60-7460,72,74 are prognostic markers of radiographic damage in the very early arthritides of the French ESPOIR cohort. Ann Rheum Dis. 2014 Mar 1;73 Suppl 1:A26. doi: 10.1136/annrheumdis-2013-205124.59. 
    voir l'article : ESPOIR 49

  50. Hmamouchi I,Combe B, Le Loet X, Fautrel B, Lukas C Prevalence, concordance and predictors of early and sustained remission assessed by various validated indices in the early arthritis "ESPOIR" cohort Joint Bone Spine 2014 Apr 1. pii: S1297-319X(14)00051-7. dos:
    voir l'article : ESPOIR 50

  51. Mouterde G, Lukas C, Flipo RM, Goupille Ph, Rincheval N, Daurès JP, Combe B. ACPA, rheumatoid factor and differences in clinical presentation of early arthritis: results from the ESPOIR Cohort. J Rheumatol 2014 Aug;41(8):1614-22. doi: 10.3899/jrheum.130884. Epub 2014 Jul 15.
    voir l'article : ESPOIR 51

  52. Bacconnier L, Rincheval, Flipo RM, Goupille P, Daures JP, Boulenger JP , Combe. B. Depression and anxiety risk in early rheumatoid arthritis: Results from the ESPOIR cohort. Rheumatology (Oxford). 2014 Sep 14. pii: keu371. [Epub ahead of print]
    voir l'article : ESPOIR 52

  53. Chevreul K, Lucie S, Haour G, Harvard S, Laroche ML, Mariette X, Saraux A, Durand-Zaleski, I, Guillemin F, Fautrel. Evolution of direct costs in the first years of rheumatoid arthritis: Impact of early versus late biologic initiation. An economic analysis based on the ESPOIR cohort. PLoS One. 2014 May 8;9(5):e97077. doi: 10.1371/journal.pone.0097077. eCollection 2014
    voir l'article : ESPOIR 53

  54. Ruyssen-Witrand A, Guernec G, Nigon D, Tobon G, Jamard B, Rat AC, Vittecoq O, Cantagrel A, Constantin A. Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes. Ann Rheum Dis. 2014 May 2. doi: 10.1136/annrheumdis-2013-204906. [Epub ahead of print
    voir l'article : ESPOIR 54

  55. Juge PA, van Steenbergen HW, Constantin A, Tobon GJ, Schaeverbeke T, Gazal S, Combe B, Devauchelle-Pensec V, Nigon D, van der Helm-van Mil AH, Dieude P.SPP1 rs9138 variant contributes to the severity of radiological damage in anti-citrullinated protein autoantibody-negative rheumatoid arthritis.Ann Rheum Dis. 2014 Oct;73(10):1840-3. doi: 10.1136/annrheumdis-2014-205539. Epub 2014 Jun 16.
    voir l'article : ESPOIR 55

  56. Toussirot E, Dumoulin G.Response to 'Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort'- authors' reply. Arthritis Res Ther. 2014;16(2):407. Epub 2014 Apr 10.
    voir l'article : ESPOIR 56

  57. Sellam J, Fellahi S, Bastard JP, Capeau J, Berenbaum F. Response to 'Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort' - authors' reply.Arthritis Res Ther. 2014;16(2):408. Epub 2014 Apr 10
    voir l'article : ESPOIR 57

  58. Combe B, Rincheval N.Early lessons from the recent-onset rheumatoid arthritis cohort ESPOIR. Joint Bone Spine. 2014 Sep 16. pii: S1297-319X(14)00184-5. doi: 10.1016/j.jbspin.2014.07.003. [Epub ahead of print]
    voir l'article : ESPOIR 58

  59. Baillet A, Gossec L, Paternotte S, Combe B, Meyer O, Mariette X, Gottenberg JE, Dougados M. . Evaluation of serum IL-6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: Results from the ESPOIR cohort. Arthritis Care Res (Hoboken). 2014 Nov 10. doi: 10.1002/acr.22513. [Epub ahead of print]
    voir l'article : ESPOIR 59

  60. Combe B. ESPOIR and the French database management: what have we learned from the first years of follow-up? Clin Exp Rheumatol. 2014 Nov-Dec;32 Suppl 85(5):153-157. Epub 2014 Oct 30.  
    voir l'article : ESPOIR 60

  61. Durán J, Combe B, Niu J, Rincheval N, Gaujoux-Viala C, Felson D. The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort. Rheumatology 2015 Jul 14. pii: kev254. [Epub ahead of print] 
    voir l'article : ESPOIR 61

  62. Van Nies JA, Tsonaka R, Gaujoux-Viala C, Fautrel B, van der Helm-van Mil AH. Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden Early Arthritis Clinic and ESPOIR cohorts. Ann Rheum Dis. 2015 Jan 5. pii: annrheumdis-2014-206047. doi: 10.1136/annrheumdis-2014-206047. [Epub ahead of print]  
    voir l'article : ESPOIR 62

  63. Seror R1, Le Gall-David S, Bonnaure-Mallet M, Schaeverbeke T, Cantagrel A, Minet J, Gottenberg JE, Chanson P, Ravaud P, Mariette X. Anti-Porphyromonas gingivalis antibodies titres are associated with non-smoking status in early rheumatoid arthritis: Results from the ESPOIR cohort. Arthritis Rheumatol. 2015 Mar 16. doi: 10.1002/art.39118. [Epub ahead of print]  
    voir l'article : ESPOIR 63

  64. van Nies JA1, Alves C2, Radix-Bloemen AL3, Gaujoux-Viala C4, Huizinga TW5, Hazes JM6, Brouwer E7, Fautrel B8, Mil AH9 Reappraisal of the diagnostic and prognostic value of morning stiffness in arthralgia and early arthritis: results from the Groningen EARC, Leiden EARC, ESPOIR, Leiden EAC and REACH. Arthritis Res Ther. 2015 Apr 23;17:108. doi: 10.1186/s13075-015-0616-3.  
    voir l'article : ESPOIR 64

  65. Guellec D, Milin M, Cornec D, Tobon GJ, Marhadour T, Jousse-Joulin S, Chiocchia G, Vittecocq O, Devauchelle-Pensec V, Saraux A. Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort. RMD Open. 2015 Jul 15;1(1):e000070. doi: 10.1136/rmdopen-2015-000070. eCollection 2015.
    voir l'article : ESPOIR 65

  66. Ana Maria Gherghe, Maxime Dougados, Bernard Combe, Robert Landewé, Carina Mihai, Francis Berenbaum, Ron Wolterbeek, Désirée van der Heijde. Common comorbidities in early arthritis and early spondyloarthritis, a comparative study - results from the ESPOIR and DESIR cohorts RMD Open. 2015 Sep 14;1(1):e000128. doi: 10.1136/rmdopen-2015-000128. eCollection 2015  
    voir l'article : ESPOIR 66

  67. van Steenbergen HW, van Nies JA, Ruyssen-Witrand A, Huizinga TW, Cantagrel A, Berenbaum F, van der Helm-van Mil AH. IL2RA is associated with persistence of rheumatoid arthritis.Arthritis Res Ther. 2015 Sep 8;17:244. doi: 10.1186/s13075-015-0739-6  
    voir l'article : ESPOIR 67

  68. Audo R, Daien C, Papon L, Lukas C, Vittecoq O, Hahne M, Combe B, Morel J. Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort. Arthritis Res Ther. 2015 Jul 29;17:193. doi: 10.1186/s13075-015-0705-3.  
    voir l'article : ESPOIR 68

  69. Duquenne C, Cornec D, Marhadour T, Jousse-Joulin S, Cantagrel A, Pavy S, Devauchelle-Pensec V, Saraux A. Lymphopenia in early arthritis: Impact on diagnosis and 3-year outcomes (ESPOIR cohort).Joint Bone Spine. 2015 Jul 13. pii: S1297-319X(15)00119-0. doi: 10.1016/j.jbspin.2015.02.012. [Epub ahead of print] 
    voir l'article : ESPOIR 69

  70. Degboé Y, Constantin A, Nigon D, Tobon G, Cornillet M, Schaeverbeke T, Chiocchia G, Nicaise-Roland P, Nogueira L, Serre G, Cantagrel A, Ruyssen-Witrand A. Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1 year: results from the ESPOIR cohort. RMD Open. 2015 Nov 26;1(1):e000180  
    voir l'article : ESPOIR 70

  71. Ruyssen-Witrand A, van Steenbergen HW, van Heemst J, Gourraud PA, Nigon D, Lukas C, Miceli-Richard C, Jamard B, Cambon-Thomsen A, Cantagrel A, Dieudé P, van der Helm-van Mil AH, Constantin A. A new classification of HLA-DRB1 alleles based on acid-base properties of the amino acids located at positions 13, 70 and 71: impact on ACPA status or structural progression, and meta-analysis on 1235 patients with rheumatoid from two cohorts (ESPOIR and EAC cohort).RMD Open. 2015 Nov 19;1(1):e000099
    voir l'article : ESPOIR 71

  72. Seror R, Boudaoud S, Pavy S, Nocturne G, Schaeverbeke T, Saraux A, Chanson P, Gottenberg JE, Devauchelle-Pensec V, Tobón GJ, Mariette X, Miceli-Richard C. Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort. Sci Rep. 2016 Jan 20;6:18421. doi: 10.1038/srep18421. PMID: 26785768 74) 
    voir l'article : ESPOIR 72

  73. Guellec D, Narbonne V, Cornec D, Marhadour T, Varache S, Dougados M, Daurès JP, Jousse-Joulin S, Devauchelle-Pensec V, Saraux A. Diagnostic impact of routine Lyme serology in recent-onset arthritis: results from the ESPOIR cohort. RMD Open. 2016 Jan 11;2(1):e000120. doi: 10.1136/rmdopen-2015-000120. eCollection 2016.
    voir l'article : ESPOIR 73

  74. Granger B, Combe B, Le Loet X, Saraux A, Guillemin F, Fautrel B. Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort data. RMD Open. 2016;2(1):e000245. doi:10.1136/rmdopen-2016-000245.
    voir l'article : ESPOIR 74

  75. Couderc M, Pereira B, Combe B, Devauchelle-Pensec V, Mariette X, Soubrier M. Comparison of modified disease-activity scores with original composite scores for prediction of structural damages in rheumatoid arthritis: Data from the ESPOIR cohort. doe:10.1016/j.jbspin.2015.12.009
    voir l'article : ESPOIR 75

  76. Castrejón I, Dougados M, Combe B, Fautrel B, Guillemin F,  Pincus T. Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions. The Journal of Rheumatology Apr 2016, jrheum.141586; DOI: 10.3899/jrheum.141586
    voir l'article : ESPOIR 76

  77. Krams T, Ruyssen-Witrand A, Nigon D, Degboe Y, Tobon G, Fautrel B, Berenbaum F, Cantagrel A, Constantin A. Effect of age at rheumatoid arthritis onset on clinical, radiographic, and functional outcomes: The ESPOIR cohort, Volume 4865, Issue 5, 10/2016, Pages 471-613, ISSN 1297-319X, http://dx.doi.org/10.1016/j.jbspin.2015.09.010
    voir l'article : ESPOIR 77

  78. Cornillet M, Ajana S, Ruyssen-Witrand A, Constantin A, Degboé Y, Cantagrel A, Meyer O, Serre G, Nogueira L; Autoantibodies to human citrullinated fibrinogen and their subfamilies to the α36-50Cit and β60-74Cit fibrin peptides similarly predict radiographic damages: a prospective study in the French ESPOIR cohort of very early arthritides. Rheumatology (Oxford) 2016; 55 (10): 1859-1870. doi: 10.1093/rheumatology/kew014
    voir l'article : ESPOIR 78

  79. Che H, Combe B, Morel J, Cantagrel A, Gossec L, Lukas C. Performance of patient-reported outcomes in the assessment of rheumatoid arthritis disease activity:the experience of the ESPOIR cohort. Clin Exp Rheumatol. 2016 Jul-Aug; 34(4): 646–654. Published online 2016 Jun 22.
    voir l'article : ESPOIR 79

  80. Ruyssen-Witrand A, Degboé Y, Cantagrel A, Nigon D, Lukas C, Scaramuzzino S, Allanore Y, Vittecoq O, Schaeverbeke T, Morel J, Sibilia J, Cambon-Thomsen A, Dieudé P, Constantin A. Association between RANK, RANKL and OPG polymorphisms with ACPA and erosions in rheumatoid arthritis: results from a meta-analysis involving three French cohorts. RMD Open. 2016;2(2):e000226. doi:10.1136/rmdopen-2015-000226.
    voir l'article : ESPOIR 80

  81. Tournadre A, Pereira B, Dubost JJ, Rincheval N, Rat AC, Combe B, Soubrier M. Management of dyslipidaemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-up. Clin Exp Rheumatol. 2017 Mar-Apr;35(2):296-302. Epub 2017 Jan 4. PMID: 28079508
    voir l'article : ESPOIR 81

  82. Gandjbakhch F, Granger B, Freund R, Foltz V, Jousse-Joulin S, Devauchelle V, Afshar M, Albert JD, Bailly F, Constant E, Biale L, Milin M, Couderc M, Denarie D, Fradin A, Martaille V, Pierreisnard A, Poursac N, Saraux A, Fautrel B. Multireader assessment as an alternative to reference assessment to improve the detection of radiographic progression in a large longitudinal cohort of rheumatoid arthritis (ESPOIR). RMD Open. 2017 Jan 4;3(1):e000343. doi: 10.1136/rmdopen-2016-000343. eCollection 2017. PubMed PMID: 28123779; PubMed Central PMCID: PMC5237761.
    voir l'article : ESPOIR 82

  83. Roubille C, Rincheval N, Dougados M, Flipo RM, Daurès JP, Combe B. Seven-year tolerability profile of glucocorticoids use in early rheumatoid arthritis: data from the ESPOIR cohort. Ann Rheum Dis. 2017 Feb 17. pii: annrheumdis-2016-210135. doi: 10.1136/annrheumdis-2016-210135. [Epub ahead of print] PMID: 28213564
    voir l'article : ESPOIR 83

  84. Durán J, Combe B, Niu J, Rincheval N, Gaujoux-Viala C, Felson DT.The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort. Rheumatology (Oxford). 2017 Apr 3. doi: 10.1093/rheumatology/kew472. [Epub ahead of print]
    voir l'article : ESPOIR 84

  85. Boeters DM, Gaujoux-Viala C, Constantin A, van der Helm-van Mil AHM. The 2010 ACR/EULAR criteria are not sufficiently accurate in the early identification of autoantibody-negative rheumatoid arthritis: results from the Leiden-EAC and ESPOIR cohorts.Semin Arthritis Rheum. 2017 Oct;47(2):170-174. doi: 10.1016/j.semarthrit.2017.04.009. Epub 2017 Apr 29
    voir l'article : ESPOIR 85

  86. Boeters DM, Mangnus L, Ajeganova S, Lindqvist E, Svensson B, Toes REM, Trouw LA, Huizinga TWJ, Berenbaum F, Morel J, Rantapää-Dahlqvist S, van der Helm-van Mil AHM. The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical.Arthritis Res Ther. 2017 May 31;19(1):115. doi: 10.1186/s13075-017-1324-y
    voir l'article : ESPOIR 86

  87. Gaujoux-Viala C, Rincheval N, Dougados M, Combe B, Fautrel B. Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort. Ann Rheum Dis. 2017 Sep 2. pii: annrheumdis-2017-211268. doi: 10.1136/annrheumdis-2017-211268. [Epub ahead of print]
    voir l'article : ESPOIR 87

  88. Truchetet ME, Dublanc S, Barnetche T, Vittecoq O, Mariette X, Richez C, Blanco P, Mahler M, Contin-Bordes C, Schaeverbeke T; FHU ACRONIM. Anti-carbamylated protein antibodies presence in early arthritis with a poorer clinical and radiological outcome: data from the French ESPOIR cohort.Arthritis Rheumatol. 2017 Aug 29. doi: 10.1002/art.40237. [Epub ahead of print]
    voir l'article : ESPOIR 88

 

 

Manuscrits soumis